Illumina Inc. has agreed to pay $9.8 million to resolve allegations that it violated the False Claims Act after the company sold genomic sequencing systems with cybersecurity vulnerabilities to federal agencies, according to the U.S. Department of Justice. Illumina, headquartered …
Source: Claims Journal